Global Restructuring Review - Cross-border restructuring and insolvency legal news, features and events

Purdue Pharma denies EY conflicts of interest, fraudulent transfers

By Declan Bush

19 November 2019

Bankrupt US OxyContin maker Purdue Pharma has denied claims its plan to hire EY would create a conflict of interest, as it fights fraudulent transfer claims raised in the US Supreme Court.

Purdue Pharma denies EY conflicts of interest, fraudulent transfers Purdue Pharma entered bankruptcy in September facing thousands of lawsuits over the opioid crisis. (Credit: iStock.com/BackyardProduction)